GSK2586184,
Solcitinib,
1206163-45-2,
GLPG-0778,
GLPG0778,
GSK2586184,
UNII-3V7GQ1260K,
GLPG 0778,
GSK2586184A,
GSK 2586184,
GSK-2586184,
3V7GQ1260K,
AK171373,
G154578,
N-(5-(4-(3,3-Dimethylazetidine-1-carbonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide,
N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide,
Solcitinib [USAN:INN],
Solicitinib,
Cyclopropanecarboxamide, N-(5-(4-((3,3-dimethyl-1-azetidinyl)carbonyl)phenyl)(1,2,4)triazolo(1,5-a)pyridin-2-yl)-,
Cyclopropanecarboxamide, N-[5-[4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]-,
N-{5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}cyclopropanecarboxamide,
Solcitinib (USAN/INN),
GLPG-0778;Solcitinib,
GTPL9697,
SCHEMBL2240393,
CHEMBL3301606,
GLPG-0788,
MPYACSQFXVMWNO-UHFFFAOYSA-N,
BDBM128101,
BCP23893,
EX-A2326,
GSK 2586184A,
GSK-2586184A,
MFCD26960569,
AKOS025289798,
compound 1 [WO2010149771],
ZINC118401631,
CS-5204,
SB16965,
NCGC00484062-01,
HY-16755,
A14405,
D10728,
US8796457, 1,
G-154578,
Solcitinib pound GLPG0778 GSK2586184 pound(c),
cyclopropanecarboxylic acid {5-[4-(3,3-dimethyl-azetidine-1-carbonyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}-amide,
cyclopropanecarboxylic acid{5-[4-(3,3-dimethyl-azetidine-1-carbonyl)-phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl}-amide,
N-(5-(4-((3,3-dimethylazetidin-1-yl)carbonyl)phenyl)(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide,